PF-Atlas › Clinical Trials › NCT00743483

Efficacy of Bucelipase Alfa in Patients With Cystic Fibrosis and Pancreatic Insufficiency

rhBSSL · Phase 2

Registry ID

NCT00743483

Phase

Phase 2

Status

Completed

Drug / intervention

rhBSSL

Sponsor

Swedish Orphan Biovitrum

Start

2008-08

About this trial

rhBSSL is evaluated in NCT00743483, a Phase 2 idiopathic pulmonary fibrosis study sponsored by Swedish Orphan Biovitrum. Current status: Completed.

View NCT00743483 on ClinicalTrials.gov →

Explore related

All rhBSSL trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT00743483 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.